Teva Pharmaceutical Industries total non-operating income/expense for the twelve months ending June 30, 2024 was $-1.020B, a 0.49% decline year-over-year.
Teva Pharmaceutical Industries annual total non-operating income/expense for 2023 was $-1.057B, a 9.42% increase from 2022.
Teva Pharmaceutical Industries annual total non-operating income/expense for 2022 was $-0.966B, a 8.7% decline from 2021.
Teva Pharmaceutical Industries annual total non-operating income/expense for 2021 was $-1.058B, a 26.86% increase from 2020.
Teva Pharmaceutical Industries Total Non-Operating Income/Expense 2010-2024 | TEVA